[Functional degradation of myelin basic protein. Proteomic approach]

Area of Science:

• Biochemistry
• Immunology
• Neuroscience

Background:

• Proteolytic degradation of autoantigens is crucial in immunology.
• Altered peptide fragments can serve as diagnostic markers for disease progression.
• Understanding these changes is key to addressing autoimmune processes.

Purpose of the Study:

• To comparatively study the degradation of myelin basic protein (MBP) by specific proteases and proteasomes.
• To investigate how these degradation patterns change during demyelinating diseases.
• To analyze the implications for major histocompatibility complex class I (MHC I) presentation.

Main Methods:

• Comparative analysis of MBP degradation by disease-activated proteases.
• Proteasome-mediated degradation studies using proteasomes from various sources.
• Analysis of resulting peptide fragments and their potential for MHC I presentation.

Main Results:

• Different proteases and proteasomes yield distinct MBP peptide fragments.
• Specific degradation patterns are associated with the progression of demyelinating processes.
• A critical change in the repertoire of MBP peptides presented by MHC I was observed.

Conclusions:

• The specificity of MBP degradation significantly impacts the peptides presented by MHC I during neurodegeneration.
• Altered peptide presentation may contribute to the progression of autoimmune pathological processes.
• These findings highlight potential diagnostic and prognostic avenues in neurodegenerative diseases.